La colite microscopique (notice n° 665742)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02874cam a2200337 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250121194029.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Bresteau, Clément |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | La colite microscopique |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2023.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 36 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Microscopic colitis is a common inflammatory disease of the large intestine responsible for a chronic secretory diarrhea. Microscopic colitis is caused by an inappropriate immune response triggered by pharmacological and/or environmental factors. The diagnosis of microscopic colitis relies on histological assessment of colonic biopsy samples. Microscopic colitis is either categorized into collagenous or lymphocytic colitis. The mainstay of treatment relies on budesonide and withdrawal of deleterious drugs. The benefits of immunomodulators and biological agents in refractory microscopy colitis is currently emerging in patients with resistance or intolerance to budesonide. A better understanding of the immune response in disease pathogenesis may afford new therapeutic strategy in the upcoming years. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | La colite microscopique est une colite inflammatoire fréquente responsable d’une diarrhée sécrétoire chronique. Sa physiopathologie reste mal connue. Elle est d’origine médicamenteuse dans près de la moitié des cas ou idiopathique, causée par une altération de la réponse immunitaire en réponse à des facteurs environnementaux. Le diagnostic de la colite microscopique repose sur l’analyse histologique de biopsies coliques multiples. On distinguera la colite lymphocytaire et la colite collagène. Le traitement repose en grande partie sur le budésonide et sur l’éviction d’un médicament incriminé dans sa pathogénie. La place des immunosuppresseurs et des biothérapies émerge peu à peu chez les patients intolérants, dépendants et/ou réfractaires au budésonide. Des progrès dans la compréhension des mécanismes physiopathologiques à l’œuvre au cours de la colite microscopique sont nécessaires pour permettre des progrès en termes de prise en charge thérapeutique. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | colite collagène |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | colite lymphocytaire |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | colite microscopique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | budésonide |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | collagenous colitis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | microscopic colitis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | lymphocytic colitis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | budesonide Introduction |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Martin, Antoine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lazure, Thierry |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Meyer, Antoine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bellanger, Christophe |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Carbonnel, Franck |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Amiot, Aurélien |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hépato-Gastro & Oncologie Digestive | 30 | 9 | 2023-11-05 | p. 951-959 | 2115-3310 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-hepato-gastro-et-oncologie-digestive-2023-9-page-951?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-hepato-gastro-et-oncologie-digestive-2023-9-page-951?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux